DMXL2 and breast carcinoma: In another paper, it was declared that DMXL2 was increased in some endocrine therapy resistant breast cancer cells where DMXL2 promoted EMT via activating Notch signaling through V-type ATPase dependent acidification (Faronato et al., 2015).